People with multiple sclerosis (MS) may find it more difficult to recognise emotions in other people, and experience more intense emotions than those without the condition, a new study has found.
It...
Exposure to the cold may stop and even undo demyelination caused by multiple sclerosis (MS), a new mouse-model study from the University of Geneva suggests.
Scientists induced an MS-like condition in...
Never drinking alcohol increases your risk of developing multiple sclerosis (MS), a new study has found, especially if you smoke or used to smoke.
Previous studies have found that alcohol decreases...
Ponvory (ponesimod) has been approved for use on the NHS in Scotland by the Scottish Medicines Consortium (SMC) for relapsing remitting multiple sclerosis (MS).
Ponvory is taken daily in tablet form...
Experiencing abuse during childhood is associated with a higher risk of getting multiple sclerosis (MS) in later life, a Norwegian study has found.
Both emotional and sexual abuse were linked to MS...
Treatment with mesenchymal stem cells (MSCs) has failed to significantly reduce inflammation in the brain of adults with multiple sclerosis (MS) in a phase 2 clinical trial. The into-the-vein...
Quitting smoking may slow disease progression in people with multiple sclerosis (MS) a new large real-world study has found.
Researchers found that in people who had quit smoking, disease progression...
The National Institute for Health and Care Excellence (NICE) is not recommending Ponvory (ponesimod) is made available on the NHS in England and Wales for people with active, relapsing forms of...
A new review study has found that deep brain stimulation (DBS) can reduce tremors in people with multiple sclerosis (MS), but treatment may lead to speech problems and other symptoms worsening.
DBS...
A new study has found that John Cunningham virus mutations may be an early predictor for brain infection in people receiving Tysabri for multiple sclerosis (MS).
Tysabri works by preventing immune...
